MedPath

The Benefits of R Anastomotic Technique for Billroth-II Reconstruction With Braun Anastomosis During Totally Laparoscopic Distal Gastrectomy: a Propensity Score Matching Analysis

Completed
Conditions
the Incidences of Clavien-Dindo Grade II or Higher
Anastomotic Time
Interventions
Procedure: R anastomosis
Registration Number
NCT06404580
Lead Sponsor
Daorong Wang
Brief Summary

Between March 2019 and September 2022 in our centre, R anastomosis was performed on 123 patients undergoing TLDG for distal gastric cancer. A retrospective review of a prospectively collected database identified patients who underwent TLDG between January 2010 and September 2022. Patients who underwent R anastomosis were matched in a 1:1 ratio with patients who underwent conventional anastomosis using a propensity score based on age, sex, preoperative BMI, American Society of Anesthesiologists (ASA) score, and the history of abdominal surgery. Surgical and postoperative outcomes and clinicopathological data were analyzed for both groups.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
246
Inclusion Criteria
  1. elective surgery for endoscopic and pathological diagnosis of malignant tumour of the gastric antrum or body with no distant metastases confirmed by multilayer spiral computed tomography;
  2. patients who underwent B-II-B anastomosis during TLDG; and (3) patients who could be followed up postoperatively.
Exclusion Criteria

(1) patients who had received preoperative neoadjuvant radiotherapy or chemotherapy; (2) patients undergoing emergency surgery; (3) the presence of other malignant tumours concurrently; and (4) patients who were lost to follow-up.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
R anastomosisR anastomosis-
B-II-B anastomosisR anastomosis-
Primary Outcome Measures
NameTimeMethod
the incidences of Clavien-Dindo grade II or higher2010-2022

the incidences of Clavien-Dindo grade II or higher

anastomotic time2010-2022

anastomotic time

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Northern Jiangsu People's Hospital

🇨🇳

Yangzhou, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath